The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 07, 2025

Filed:

Oct. 26, 2023
Applicant:

Glaxosmithkline Biologicals SA, Rixensart, BE;

Inventors:

Benjamin Petsch, Tübingen, DE;

Dominik Vahrenhorst, Tübingen, DE;

Diego Chaves Moreno, Tübingen, DE;

Janina Gergen, Tübingen, DE;

Jessica Michelle Devant, Tübingen, DE;

Kristina Kovacikova, Tübingen, DE;

Hans Wolfgang Große, Tübingen, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/215 (2006.01); A61P 31/14 (2006.01); C07K 14/005 (2006.01); C07K 14/165 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/215 (2013.01); A61P 31/14 (2018.01); C07K 14/005 (2013.01); A61K 2039/53 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55555 (2013.01); C07K 14/165 (2013.01); C12N 2770/20022 (2013.01); C12N 2770/20034 (2013.01);
Abstract

The present invention is directed to nucleic acids suitable for use in treatment or prophylaxis of an infection with a coronavirus, such as a Coronavirus SARS-CoV-2 variant, or a disorder related to such an infection, such as COVID-19. The present invention is also directed to compositions, and vaccines. The compositions and vaccines comprise at least one of said nucleic acid sequences, and nucleic acid sequences in association with a lipid nanoparticle (LNP). The invention is also directed to first and second medical uses of the nucleic acids, the composition, the vaccine, and the kit, and to methods of treating or preventing a coronavirus infection, such as a Coronavirus infection from a SARS-CoV-2 variant.


Find Patent Forward Citations

Loading…